Skip to content
healthcare.dev
Get a free key

Lamzede

NDC 10122-180, Velmanase alfa-tycv, injection, powder, lyophilized, for solution, from Chiesi USA, Inc..

Product NDC
10122-180
Status
Listed
Labeler
Chiesi USA, Inc.
Dosage form
INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Route
INTRAVENOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
BLA
Application
BLA761278
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/10122-180 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • VELMANASE ALFA-TYCV10 mg/1
Package NDCNDC-11Package
10122-180-02101220180021 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 CARTON (10122-180-02)
10122-180-05101220180055 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 CARTON (10122-180-05)
10122-180-101012201801010 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 CARTON (10122-180-10)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/36d50a08-60bd-40eb-807c-778d69bf2d2e

  • Medicare Part B payment limits (ASP)

    GET /v1/drugs/asp?ndc=10122-180

Use it

Look up 10122-180 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/10122-180 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 10122-180. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Get a free keyNDC docsConnect the MCP server

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.